TY - JOUR
T1 - Dysphagia in spinocerebellar ataxias type 1, 2, 3 and 6
AU - Yang, Chen Ya
AU - Lai, Ruo Yah
AU - Amokrane, Nadia
AU - Lin, Chi Ying
AU - Figueroa, Karla P.
AU - Pulst, Stefan M.
AU - Perlman, Susan
AU - Wilmot, George
AU - Gomez, Christopher M.
AU - Schmahmann, Jeremy D.
AU - Paulson, Henry
AU - Shakkottai, Vikram G.
AU - Rosenthal, Liana S.
AU - Ying, Sarah H.
AU - Zesiewicz, Theresa
AU - Bushara, Khalaf
AU - Geschwind, Michael
AU - Xia, Guangbin
AU - Subramony, S. H.
AU - Ashizawa, Tetsuo
AU - Troche, Michelle S.
AU - Kuo, Sheng Han
N1 - Publisher Copyright:
© 2020
PY - 2020/8/15
Y1 - 2020/8/15
N2 - Background: Dysphagia is a common symptom and may be a cause of death in patients with spinocerebellar ataxias (SCAs). However, little is known about at which disease stage dysphagia becomes clinically relevant. Therefore, our study aims to investigate the prevalence of dysphagia in different disease stages of SCA 1, 2, 3 and 6. Methods: We studied 237 genetically confirmed patients with SCA 1, 2, 3, 6 from the Clinical Research Consortium for SCAs and investigated the prevalence of self-reported dysphagia and the association between dysphagia and other clinical characteristics. We further stratified ataxia severity and studied the prevalence of dysphagia at each disease stage. Results: Dysphagia was present in 59.9% of SCA patients. Patients with dysphagia had a longer disease duration and more severe ataxia than patients without dysphagia (patients with dysphagia vs. without dysphagia, disease duration (years): 14.51 ± 8.91 vs. 11.22 ± 7.82, p = .001, scale for the assessment and rating of ataxia [SARA]: 17.90 ± 7.74 vs. 13.04 ± 7.51, p = .000). Dysphagia was most common in SCA1, followed by SCA3, SCA 6, and SCA 2. Dysphagia in SCA1 and 3 was associated robustly with ataxia severity, whereas this association was less obvious in SCA2 and 6, demonstrating genotype-specific clinical variation. Conclusion: Dysphagia is a common clinical symptom in SCAs, especially in the severe disease stage. Understanding dysphagia in SCA patients can improve the care of these patients and advance knowledge on the roles of the cerebellum and brainstem control in swallowing.
AB - Background: Dysphagia is a common symptom and may be a cause of death in patients with spinocerebellar ataxias (SCAs). However, little is known about at which disease stage dysphagia becomes clinically relevant. Therefore, our study aims to investigate the prevalence of dysphagia in different disease stages of SCA 1, 2, 3 and 6. Methods: We studied 237 genetically confirmed patients with SCA 1, 2, 3, 6 from the Clinical Research Consortium for SCAs and investigated the prevalence of self-reported dysphagia and the association between dysphagia and other clinical characteristics. We further stratified ataxia severity and studied the prevalence of dysphagia at each disease stage. Results: Dysphagia was present in 59.9% of SCA patients. Patients with dysphagia had a longer disease duration and more severe ataxia than patients without dysphagia (patients with dysphagia vs. without dysphagia, disease duration (years): 14.51 ± 8.91 vs. 11.22 ± 7.82, p = .001, scale for the assessment and rating of ataxia [SARA]: 17.90 ± 7.74 vs. 13.04 ± 7.51, p = .000). Dysphagia was most common in SCA1, followed by SCA3, SCA 6, and SCA 2. Dysphagia in SCA1 and 3 was associated robustly with ataxia severity, whereas this association was less obvious in SCA2 and 6, demonstrating genotype-specific clinical variation. Conclusion: Dysphagia is a common clinical symptom in SCAs, especially in the severe disease stage. Understanding dysphagia in SCA patients can improve the care of these patients and advance knowledge on the roles of the cerebellum and brainstem control in swallowing.
KW - Aspiration
KW - Deglutition
KW - Neurodegenerative disease
KW - Spinocerebellar ataxia
UR - http://www.scopus.com/inward/record.url?scp=85085028032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085028032&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2020.116878
DO - 10.1016/j.jns.2020.116878
M3 - Article
C2 - 32454319
AN - SCOPUS:85085028032
SN - 0022-510X
VL - 415
SP - 116878
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
M1 - 116878
ER -